Zomedica Corp. Overview
Pro stress-test →Zomedica Corp. is a veterinary health company developing diagnostic and therapeutic products for companion animals and equine markets. The company focuses on addressing unmet clinical needs for veterinarians through innovative point-of-care diagnostic platforms and therapeutic devices, including its flagship TRUFORMA biosensor, Assisi Loop therapy systems, PulseVet electrohydraulic shockwave therapy, and TRUVIEW digital cytology microscope.
Strategic Profile
Pro stress-test →Zomedica operates in a growing $2.7+ billion total addressable market in veterinary diagnostics and therapeutics. The company achieved 16% year-over-year revenue growth in Q3 2025 to $8.1M with strong 67% gross margins and maintained a solid $54.4M cash position. International expansion is a key growth driver, with international sales growing 20% and strategic partnerships expanding distribution across Europe and North America.
Competitive Landscape
Pro stress-test →Zomedica competes in the fragmented veterinary diagnostics and therapeutics market against larger players like Zoetis (diagnostic platforms), regional veterinary pharmaceutical suppliers, and emerging point-of-care device manufacturers. Key competitive advantages include proprietary TRUFORMA biosensor technology, integrated therapeutic platforms (Assisi Loop, PulseVet), and strategic partnerships with distributors expanding international reach.
Industry Context
Zomedica Corp. operates in Veterinary Diagnostics and Therapeutics / Animal Health Medical Devices.
Key facts
Founded: 2013 · Headquarters: Ann Arbor, Michigan, United States · Employees: ~25 · Revenue: $8.1M (Q3 2025, annualized ~$32M)